Zhejiang Huahai
Zhejiang Huahai Pharmaceutical Co., Ltd., commonly referred to as Huahai, is a prominent player in the global pharmaceutical industry, headquartered in Zhejiang, China. Founded in 1989, the company has established itself as a leader in the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms, particularly in the fields of cardiovascular and anti-infective medications. With a strong presence in both domestic and international markets, Huahai operates in various regions, including North America, Europe, and Asia. The company is renowned for its commitment to quality and innovation, boasting a diverse portfolio of products that meet stringent regulatory standards. Notable achievements include multiple certifications from global health authorities, positioning Huahai as a trusted supplier in the pharmaceutical sector.
DitchCarbon Score
How does Zhejiang Huahai's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zhejiang Huahai's score of 27 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zhejiang Huahai's reported carbon emissions
Zhejiang Huahai Pharmaceutical Co., Ltd., headquartered in China, has set ambitious climate commitments aimed at significantly reducing its greenhouse gas emissions. Although specific emissions data for recent years is not available, the company has established near-term targets to address its carbon footprint. Zhejiang Huahai aims to reduce its absolute Scope 1 and Scope 2 greenhouse gas emissions by approximately 42% by the year 2030, using 2023 as the base year. Additionally, the company is committed to reducing its Scope 3 emissions by about 51.6% per million CNY value added, with a baseline year of 2022. These targets align with the science-based targets necessary to limit global warming to 1.5°C. The company's commitment reflects a proactive approach to sustainability within the pharmaceuticals, biotechnology, and life sciences sector, demonstrating its dedication to mitigating climate change impacts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zhejiang Huahai is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
